Skip to main content
. 2020 Dec 3;2020(12):CD013020. doi: 10.1002/14651858.CD013020.pub2

9. Results of sensitivity network meta‐analysis for the outcome mortality (low risk of bias). Prediction intervals. Treatments are ordered by P‐score (descending). Only subnetworks with > 1 design.

95% prediction intervals (risk ratios, random‐effects model)
Zoledronic acid [ 0.84, 1.25 ] [ 0.84, 1.36 ] [ 0.29, 4.15 ] [ 0.92, 1.4 ]
[ 0.8, 1.19 ] Denosumab [ 0.76, 1.42 ] [ 0.28, 4.09 ] [ 0.83, 1.48 ]
[ 0.74, 1.19 ] [ 0.71, 1.31 ] Clodronate [ 0.28, 3.84 ] [ 0.94, 1.21 ]
[ 0.24, 3.42 ] [ 0.24, 3.56 ] [ 0.26, 3.61 ] Risedronate [ 0.28, 3.82 ]
[ 0.71, 1.08 ] [ 0.68, 1.21 ] [ 0.83, 1.07 ] [ 0.26, 3.59 ] No treatment/placebo